Rasmussen encephalitis: Response to early immunotherapy in a case of immune-mediated encephalitis
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
25738166
PubMed Central
PMC4335812
DOI
10.1212/nxi.0000000000000069
PII: NEURIMMINFL2014003483
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Zobrazit více v PubMed
Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005;128:454–471. PubMed
Takahashi Y, Yamazaki E, Mine J, et al. Immunomodulatory therapy versus surgery for Rasmussen syndrome in early childhood. Brain Dev 2013;35:778–785. PubMed
Bittner S, Simon OJ, Gobel K, Bien CG, Meuth SG, Wiendl H. Rasmussen encephalitis treated with natalizumab. Neurology 2013;81:395–397. PubMed
Bien CG, Tiemeier H, Sassen R, et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia 2013;54:543–550. PubMed
Ranua J, Luoma K, Peltola J, et al. Anticardiolipin and antinuclear antibodies in epilepsy—a population-based cross-sectional study. Epilepsy Res 2004;58:13–18. PubMed
Iffland PH, II, Carvalho-Tavares J, Trigunaite A, et al. Intracellular and circulating neuronal antinuclear antibodies in human epilepsy. Neurobiol Dis 2013;59:206–219. PubMed PMC
Varadkar S, Bien CG, Kruse CA, et al. Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol 2014;13:195–205. PubMed PMC